Filter Results
:
(3,148)
Show Results For
-
All HBS Web
(3,148)
- People (7)
- News (1,129)
- Research (1,602)
- Events (3)
- Multimedia (34)
- Faculty Publications (590)
Show Results For
-
All HBS Web
(3,148)
- People (7)
- News (1,129)
- Research (1,602)
- Events (3)
- Multimedia (34)
- Faculty Publications (590)
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing...
View Details
Keywords:
AI;
Genetic Engineering;
Medicine;
Health Care and Treatment;
Genetics;
Innovation Strategy;
Business and Stakeholder Relations;
Medical Specialties;
Innovation and Invention;
Entrepreneurship;
Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- 08 Sep 2022
- Book
Gen Xers and Millennials, It’s Time To Lead. Are You Ready?
from decades of teaching students from the Gen X, Millennial, and Gen Z eras. George and coauthor Zach Clayton, CEO of the digital marketing firm Three Ships, urge young leaders to usher in a new way of doing business—one based on...
View Details
Keywords:
by Lane Lambert
- 04 Sep 2001
- Research & Ideas
Governing the Family-Run Business
Doesn't Matter The absence of effective governance is by no means confined to smaller companies. The board of a large, fourth-generation family company created painful family turmoil when it dismissed the family chairman. The dismissal...
View Details
- November 2019 (Revised April 2021)
- Case
United Technologies: Are the Parts Worth More Than the Whole?
By: Benjamin C. Esty and Daniel Fisher
After spending more than 50 years creating a diversified industrial conglomerate that Fortune magazine described as “arguably the most profitable conglomerate in America” in 2014, UTC’s CEO Greg Hayes was under pressure from activist investors (Dan Loeb and Bill...
View Details
Keywords:
Corporate Strategy;
Business Conglomerates;
Financial Management;
Corporate Governance;
Organizational Structure;
Investment Funds;
Value Creation;
Aerospace Industry;
Electronics Industry;
Industrial Products Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "United Technologies: Are the Parts Worth More Than the Whole?" Harvard Business School Case 220-018, November 2019. (Revised April 2021.)
- November 2016 (Revised December 2017)
- Case
Blake Sports Apparel and Switch Activewear: Bringing the Executive Team Together
By: Boris Groysberg and Katherine Connolly Baden
Cameron (Cam) Barker, founder and CEO of Blake Sports Apparel and Switch Activewear, manufacturers and distributers of sports apparel and accessories, was facing a challenge with his executive team. Their inability to work together on seemingly simple issues was a...
View Details
Keywords:
Team Dynamics;
Team Management;
Team Effectiveness;
Team Performance;
Executive Leadership;
Groups and Teams;
Leadership;
Performance Effectiveness;
Apparel and Accessories Industry;
United Kingdom
Groysberg, Boris, and Katherine Connolly Baden. "Blake Sports Apparel and Switch Activewear: Bringing the Executive Team Together." Harvard Business School Case 417-048, November 2016. (Revised December 2017.)
- 01 Aug 2018
- News
Inside the Emerging Economy With Millions of High-Paying Jobs
- November 2019
- Supplement
United Technologies Corp.: Are the Parts Worth More Than the Whole?
By: Benjamin C. Esty and Daniel Fisher
After spending more than 50 years creating a diversified industrial conglomerate that Fortune Magazine described as “arguably the most profitable conglomerate in America” in 2014, UTC’s CEO Greg Hayes was under pressure from activist investors (Dan Loeb and Bill...
View Details
Keywords:
Corporate Strategy;
Business Conglomerates;
Financial Management;
Corporate Governance;
Organizational Structure;
Diversification;
Valuation;
Investment Activism;
Financial Strategy;
Investment Funds;
Value Creation;
Aerospace Industry;
Electronics Industry;
Industrial Products Industry;
United States
- December 2010
- Case
Leadership, Culture, and Transition at lululemon
By: Michael Tushman, Ruth Page and Tom Ryder
The case examines leadership and organizational change within a strong culture context through a multimedia study of lululemon, a specialty retailer of high-end athletic apparel. Video segments trace the company's history from its founding in 1998 as a single retail...
View Details
Keywords:
Leading Change;
Organizational Culture;
Organizational Change and Adaptation;
Change Management;
Transition;
Growth Management;
Management Teams;
Organizational Structure;
Governing and Advisory Boards;
Apparel and Accessories Industry;
Retail Industry;
Vancouver;
United States
Tushman, Michael, Ruth Page, and Tom Ryder. "Leadership, Culture, and Transition at lululemon." Harvard Business School Multimedia/Video Case 410-705, December 2010.
- December 2014 (Revised April 2015)
- Case
Apple, Einhorn, and iPrefs
By: Carliss Y. Baldwin, Hanoch Feit, Edward A. Minasian and Brandon Van Buren
In March 2013, Apple Computer has a very large cash balance, and is under pressure to return cash to shareholders. Hedge fund manager David Einhorn thinks Apple can "unlock value" by issuing perpetual preferred stock, dubbed iPrefs. Henry Blodget, CEO of Business...
View Details
Baldwin, Carliss Y., Hanoch Feit, Edward A. Minasian, and Brandon Van Buren. "Apple, Einhorn, and iPrefs." Harvard Business School Case 215-037, December 2014. (Revised April 2015.)
- February 2002 (Revised December 2003)
- Exercise
Incentives Game, The
By: Jason R. Barro, Brian J. Hall and Jonathan Lim
This exercise provides an opportunity to gain insight about designing, negotiating, and responding to incentives. The setting is investment management. A class is divided into a certain number of investment firms. Each company has one CEO and begins with four portfolio...
View Details
Barro, Jason R., Brian J. Hall, and Jonathan Lim. "Incentives Game, The." Harvard Business School Exercise 902-197, February 2002. (Revised December 2003.)
- August 2020 (Revised November 2021)
- Case
Beyond Beer: Brewing Innovation at Molson Coors
By: Derek C. M. van Bever, Stephen P. Kaufman, James Barnett and Shaye Roseman
In March 2019, Molson Coors CEO Mark Hunter considered a request to pull forward $65 million CAD in anticipated future funding for Truss Beverages, a Toronto-based cannabis beverage company that Molson Coors created in a joint venture with a Canadian cannabis...
View Details
Keywords:
Budgets and Budgeting;
Joint Ventures;
Ethics;
Cross-Cultural and Cross-Border Issues;
Disruptive Innovation;
Innovation Strategy;
Market Entry and Exit;
Food and Beverage Industry;
United States;
Canada;
Colorado
van Bever, Derek C. M., Stephen P. Kaufman, James Barnett, and Shaye Roseman. "Beyond Beer: Brewing Innovation at Molson Coors." Harvard Business School Case 321-008, August 2020. (Revised November 2021.)
- August 1996
- Case
ThermoLase
By: William A. Sahlman and Andrew S. Janower
John Hansen, CEO of ThermoLase, must develop a plan of action to exploit the company's new development-stage revolutionary hair removal technology with negligible revenues and a $500 million market capitalization. This nascent public Thermo Electron spin out company...
View Details
Keywords:
Business or Company Management;
Corporate Entrepreneurship;
Venture Capital;
Business Strategy;
Growth and Development Strategy;
Business Plan;
Beauty and Cosmetics Industry
Sahlman, William A., and Andrew S. Janower. "ThermoLase." Harvard Business School Case 897-002, August 1996.
- May 2024
- Case
SofMedica Group: Managing Growth
By: Boris Groysberg and Sarah L. Abbott
SofMedica Group had expanded from its origins as a medical equipment distributor in Romania to a holding company with four business lines operating in six countries. This expansion had been driven by SofMedica’s mission: to make cutting edge medical technology...
View Details
Keywords:
Growth;
Healthcare Access;
Healthcare;
Medical Devices;
Medical Equipment & Devices;
Medical Care;
Developing Countries;
Eastern Europe;
Quality Management System;
Health Care and Treatment;
Growth Management;
Education;
Organizational Change and Adaptation;
Quality;
Leadership;
Mission and Purpose;
Expansion;
Health Industry;
Medical Devices and Supplies Industry;
Europe;
Romania
Groysberg, Boris, and Sarah L. Abbott. "SofMedica Group: Managing Growth." Harvard Business School Case 424-027, May 2024.
- 26 May 2022
- HBS Case
Apple vs. Feds: Is iPhone Privacy a Basic Human Right?
Apple CEO Tim Cook didn’t come to his post with an activist agenda, yet when law enforcement officials began pressuring the company to hand over iPhone users’ data without their permission, Cook took what he believed was a moral stance to...
View Details
Keywords:
by Avery Forman
- 06 Feb 2018
- First Look
First Look at New Research and Ideas: February 6, 2018
Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53817 November–December 2017 Marketing Science Match Your Own Price? Self-Matching as a Retailer's Multichannel Pricing Strategy By: Kireyev, Pavel, Vineet Kumar, and Elie Ofek Abstract—Multichannel...
View Details
- March 2011 (Revised June 2011)
- Case
QuikTrip
QuikTrip, a large convenience store chain with over 500 stores, was known for its outstanding labor practices and fast, reliable, and friendly customer service. In November 2010, the CEO Chet Cadieux, had to decide how many new locations to open when QuikTrip entered a...
View Details
Keywords:
Customer Focus and Relationships;
Employees;
Growth and Development Strategy;
Logistics;
Service Delivery;
Performance Effectiveness;
Expansion;
Retail Industry;
United States
Ton, Zeynep. "QuikTrip." Harvard Business School Case 611-045, March 2011. (Revised June 2011.)
- September 2020 (Revised July 2021)
- Case
Moderna (A)
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman
In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital...
View Details
Keywords:
COVID-19;
Vaccine;
Digital Organizations;
Organizational Structure;
Operations;
Management;
Health Pandemics;
Research and Development;
Goals and Objectives
Iansiti, Marco, Karim R. Lakhani, Hannah Mayer, and Kerry Herman. "Moderna (A)." Harvard Business School Case 621-032, September 2020. (Revised July 2021.)
- 16 Jul 2012
- Research & Ideas
Are You a Strategist?
From its early days, the book explains, IKEA set out to create "a better everyday life for the many." The retailer did this by addressing an unmet market need, offering customers an extensive range of practical, well-designed furnishings...
View Details
Keywords:
by Carmen Nobel
- October 2016 (Revised October 2017)
- Case
Going Rogue: Choson Exchange in North Korea
By: Sophus A. Reinert, Dawn H. Lau and Amy MacBeath
In mid-2015, the Singapore-based CEO of Choson Exchange Geoffrey See pondered his next move. He had founded Choson Exchange as a non-profit in 2009 to further female entrepreneurship in North Korea by providing business and legal training in the isolated country. Now,...
View Details
Reinert, Sophus A., Dawn H. Lau, and Amy MacBeath. "Going Rogue: Choson Exchange in North Korea." Harvard Business School Case 717-015, October 2016. (Revised October 2017.)
- January 2001 (Revised May 2003)
- Case
Novartis Pharma: The Business Unit Model
By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing)....
View Details
Keywords:
Restructuring;
Recruitment;
Product Marketing;
Organizational Structure;
Problems and Challenges;
Health Industry;
Pharmaceutical Industry
Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.)